Windtree Therapeutics Inc (NAS:WINT)
$ 0.2552 -0.0137 (-5.09%) Market Cap: 2.29 Mil Enterprise Value: 2.01 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 22/100

Windtree Therapeutics Inc Annual Shareholders Meeting Transcript

Aug 15, 2023 / 01:00PM GMT
Release Date Price: $29.16 (+7.29%)
Craig Fraser
Windtree Therapeutics, Inc. - CEO & President

Hello, ladies and gentlemen. I would like to officially call the meeting to order and welcome all of you to our Annual Meeting of Stockholders. I'm Craig Fraser, Chief Executive Officer of the company and Chair of the Board of Directors, and I'll be presiding over this meeting. We appreciate your participation today.

Before proceeding to the business of the meeting, I'd like to introduce our directors and members of our management team here today. In addition to myself, the following members of the Board of Directors are also present. Leslie Williams, Lead Independent Director and Chair of the Nominating and Corporate Governance Committee; Dan Geffken, Chair of the Audit Committee; Dr. Robert Scott, Chair of the Compensation Committee; and Dr. Mark Strobeck. In addition, Dr. Steve Simonson, our Chief Medical Officer; Eric Curtis, our Chief Operating Officer; and John Tattory, our Interim Chief Financial Officer, are also present.

We will conduct business of our annual meeting first, and upon adjournment, members of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot